Recombinant SARS-COV-2 Spike S1 (D614G) Protein
Applications
Reactivity
| Overview | |
| Catalog # | bs-46010P |
| Product Name | Recombinant SARS-COV-2 Spike S1 (D614G) Protein |
| Applications |
WB
ELISA
HPLC
|
| Reactivity | SARS-CoV-2 |
| Specifications | |
| Conjugation | Unconjugated |
| Source | SARS-COV-2 Spike S1 (D614G) Protein is expressed with a His-tag and Avi at the C-terminal. |
| Storage Buffer | Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization. |
| Storage Condition | The product should be stored at -70°C or -20°C. |
| Target | |
| Swiss Prot | QHD43416.1 |
| Background | The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. |
Frequently asked questions
Which applications is Recombinant SARS-COV-2 Spike S1 (D614G) Protein (bs-46010P) validated for, and at what dilution?
bs-46010P is validated for WB, ELISA, HPLC.
Which species does Recombinant SARS-COV-2 Spike S1 (D614G) Protein (bs-46010P) react with?
Tested reactivity: SARS-CoV-2.
How should bs-46010P be stored?
The product should be stored at -70°C or -20°C. Storage buffer: Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.
How is Recombinant SARS-COV-2 Spike S1 (D614G) Protein (bs-46010P) produced?
SARS-COV-2 Spike S1 (D614G) Protein is expressed with a His-tag and Avi at the C-terminal.